Table 4

Five-year outcome for patients with rheumatoid arthritis with persistent moderate disease activity (group 1) and sustained DAS28 remission (group 2) during the first year of follow-up

Outcome variableGroup 1
(n=107)
Group 2
(n=155)
p Value
DAS28 remission (%)39.280.7<0.0001
SDAI remission (%)24.059.6<0.0001
ACR/EULAR remission* (%)21.547.40.0003
HAQ–DI0.58±0.590.21±0.38<0.0001
HAQ–DI <0.5 (%)51.680.7<0.0001
Missed workdays†272.2±338.945.2±90.20.0006
No missed workdays=0‡ (%)46.762.60.011
  • Data are mean±SD unless indicated.

  • *Boolean definition; †mean missed workdays since baseline; ‡percentage of patients without any missed workdays during follow-up.

  • ACR/EULAR, American College of Rheumatology/European League Against Rheumatism; DAS28, Disease Activity Score in 28 joints; HAQ-DI, Health Assessment Questionnaire-Disability Index; SDAI, Simplified Disease Activity Index.